Search results

Narrow your search

Result types

Showing 1101 - 1110 of 2137 for "Zhong Lun Law Firm" with applied filters

News & Analysis

Han Kun provides data compliance counsel to Lucas GC's listing on Nasdaq

06 March 2024 by Han Kun Law Offices

Han Kun provides data compliance counsel to Lucas GC's listing on Nasdaq

News & Analysis

Singapore High Court clarifies prospective consent for disposition of property under the Insolvency, Restructuring and Dissolution Act (“IRDA”) 2018 prior to a bankruptcy order

28 February 2024 by Yuen Law - Singapore : by Tris Xavier

Singapore High Court clarifies prospective consent for disposition of property under the Insolvency, Restructuring and Dissolution Act (“IRDA”) 2018 prior to a bankruptcy order

News & Analysis

Biological Material and Written Description Requirement under Patent Law

29 January 2024 by DPS Parmar (Special Counsel)

The three tenets of a patent grant are possession, disclosure, and claims of invention.

News & Analysis

Quid Pro Quo of Patent Bargain: Disclosure of Invention

16 January 2024 by Manisha Singh (Partner) & Vaneet Kaur (Managing Associate)

The exclusive right of a patentee to stop others from making or using their invention for a defined period is balanced by the obligation to disclose the invention in detail.

News & Analysis

RS Helikopter GmbH AnJie Broad assisted Rode Helicopter in its wholly-owned acquisition of a German coaxial twin-rotor helicopter R&D and manufacturing enterprise RS Helikopter GmbH

08 January 2024 by AnJie Broad Law Firm

RS Helikopter GmbH AnJie Broad assisted Rode Helicopter in its wholly-owned acquisition of a German coaxial twin-rotor helicopter R&D and manufacturing enterprise RS Helikopter GmbH

News & Analysis

First Insights into China’s New Corporate Landscape

05 January 2024 by Ray SHI, Claire XU

Barely a week ago on December 29, 2023, China’s legislative body passed and President Xi Jinping signed into law the newly revised Company Law, effective from July 1, 2024 (the “New Law”).

News & Analysis

Anatomy of Licensing Deals from China Regulatory Perspective

04 January 2024 by Aaron GU, Pengfei YOU, Duzhiyun ZHENG, Yuzhen ZHANG, Fengqi YU

Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.

News & Analysis

Sponsored briefing: The foreign acquisition of Chinese enterprises

03 January 2024 by Hui Ye Law Firm - China

Wu Dong of Hui Ye Law Firm discusses the key points necessary for understanding the foreign acquisition of Chinese state-owned enterprises

News & Analysis

Foreign Acquisition of Chinese State-Owned Enterprises

03 January 2024 by Hui Ye Law Firm - China

Wu Dong and Sun Xiaoning from Hui Ye Law Firm highlight a number of considerations that warrant particular attention from foreign investors seeking to acquire state-owned enterprises in China.

News & Analysis

ESG Banking Products in China — (I) Green Deposits

03 January 2024 by Ting ZHENG, Raymond YAN, Eryin YING, Lin ZHU

ESG is in high alignment with China’s “dual carbon” goals and has become an important indicator for measuring the sustainable and high-quality development of enterprises in China